Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aclarion, Inc. - Common Stock (NQ: ACON )

0.1633 -0.0066 (-3.88%)
Streaming Delayed Price Updated: 3:58 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 228,816
Open 0.1600
Bid (Size) 0.1600 (62)
Ask (Size) 0.1697 (2)
Prev. Close 0.1699
Today's Range 0.1600 - 0.1744
52wk Range 0.1599 - 7.398
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga

Performance

YTD
-95.08%
-95.08%
1 Month
-4.11%
-4.11%
3 Month
-32.83%
-32.83%
6 Month
-49.74%
-49.74%
1 Year
-96.29%
-96.29%

More News

Read More
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Aclarion, Inc.’s (NASDAQ: ACON) Emerging Role in the Back Pain Management Sector
Via AB Newswire
ACON Stock Earnings: Aclarion Reported Results for Q1 2024
Via InvestorPlace
Aclarion, Inc.’s (NASDAQ: ACON) Emerging Role in the Back Pain Management Sector
Via News Direct
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
Via NewMediaWire
Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Micron To $140? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
Via NewMediaWire
ACON Stock Earnings: Aclarion Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Aclarion Announces First Commercial Agreement in Michigan
Via NewMediaWire
Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK
Via NewMediaWire
Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK
Via NewMediaWire
Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
Via NewMediaWire
Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London
Via NewMediaWire
Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property
Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.